• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫应答模式随慢性乙型肝炎的自然史而变化。

Immune response pattern varies with the natural history of chronic hepatitis B.

机构信息

Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.

Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.

出版信息

World J Gastroenterol. 2019 Apr 28;25(16):1950-1963. doi: 10.3748/wjg.v25.i16.1950.

DOI:10.3748/wjg.v25.i16.1950
PMID:31086463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6487378/
Abstract

BACKGROUND

Chronic hepatitis B is a highly heterogeneous disease that can be divided into four phases: Immune tolerant (IT), immune active (IA), inactive carrier (IC) and hepatitis B envelope antigen (HBeAg)-negative hepatitis (ENEG).

AIM

To investigate the immune status of natural killer (NK) and T cells in different phases of chronic hepatitis B.

METHODS

The frequency, phenotype and function of circulating NK cells, as well as nonantigen-specific and hepatitis B virus (HBV)-specific T cell responses were detected by flow cytometry in healthy and HBV-infected subjects.

RESULTS

The ability of NK cells to produce IFN-γ was markedly attenuated in HBV-infected patients overall but was less compromised in IC patients. Patients in the IT and IA phases also displayed significantly lower TNF-α production compared to healthy subjects. NK cells were phenotypically activated in the IA and ENEG phases, as evidenced by the upregulation of NKp44 in CD56 NK cells and CD69 in CD56 NK cells. Furthermore, global T-cells from the ENEG phase displayed a proinflammatory cytokine profile with upregulated IFN-γ and TNF-α expression, while this profile was suppressed in IT and IA patients. Finally, core and S antigen-specific T cell responses were significantly stronger after expansion in the IC phase compared to other phases.

CONCLUSION

Our findings demonstrate the changes in immune response pattern during the natural history of HBV infection. Both NK and T cells are functionally impaired in the IT and IA phases. With the spontaneous clearance of HBeAg and hepatitis B surface antigen decline, NK cell cytokine production and HBV-specific T responses are partially restored in IC phase, and the ENEG phase is dominated by nonantigen-specific T cell responses.

摘要

背景

慢性乙型肝炎是一种高度异质性的疾病,可以分为四个阶段:免疫耐受(IT)、免疫激活(IA)、非活动期携带者(IC)和乙型肝炎包膜抗原(HBeAg)阴性肝炎(ENEG)。

目的

研究慢性乙型肝炎不同阶段自然杀伤(NK)和 T 细胞的免疫状态。

方法

采用流式细胞术检测健康和乙型肝炎病毒(HBV)感染者循环 NK 细胞的频率、表型和功能,以及非抗原特异性和 HBV 特异性 T 细胞反应。

结果

NK 细胞产生 IFN-γ的能力在 HBV 感染者中总体上明显减弱,但在 IC 患者中受损程度较小。IT 和 IA 期患者与健康受试者相比,TNF-α的产生也显著降低。IA 和 ENEG 期 NK 细胞表型激活,CD56 NK 细胞中 NKp44上调,CD56 NK 细胞中 CD69上调。此外,ENEG 期的总 T 细胞表现出促炎细胞因子谱,IFN-γ和 TNF-α表达上调,而 IT 和 IA 期患者的这种谱被抑制。最后,与其他阶段相比,IC 期核心和 S 抗原特异性 T 细胞反应在扩增后显著增强。

结论

我们的研究结果表明,在 HBV 感染的自然史中,免疫反应模式发生了变化。在 IT 和 IA 期,NK 和 T 细胞的功能均受损。随着 HBeAg 和乙型肝炎表面抗原的自发清除,IC 期 NK 细胞细胞因子产生和 HBV 特异性 T 反应部分恢复,ENEG 期主要由非抗原特异性 T 细胞反应主导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/0b69267c3d0a/WJG-25-1950-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/d298b8d87c3b/WJG-25-1950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/8337d1d06225/WJG-25-1950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/5d9024551156/WJG-25-1950-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/1842e97a5a2a/WJG-25-1950-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/816c03dfbc29/WJG-25-1950-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/0b69267c3d0a/WJG-25-1950-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/d298b8d87c3b/WJG-25-1950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/8337d1d06225/WJG-25-1950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/5d9024551156/WJG-25-1950-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/1842e97a5a2a/WJG-25-1950-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/816c03dfbc29/WJG-25-1950-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90bb/6487378/0b69267c3d0a/WJG-25-1950-g006.jpg

相似文献

1
Immune response pattern varies with the natural history of chronic hepatitis B.免疫应答模式随慢性乙型肝炎的自然史而变化。
World J Gastroenterol. 2019 Apr 28;25(16):1950-1963. doi: 10.3748/wjg.v25.i16.1950.
2
Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.自然杀伤细胞有助于乙型肝炎 e 抗原阴性慢性乙型肝炎病毒感染进展过程中的肝损伤,并有助于病毒持续存在。
Clin Microbiol Infect. 2016 Aug;22(8):733.e9-733.e19. doi: 10.1016/j.cmi.2016.05.009. Epub 2016 May 18.
3
Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B.慢性乙型肝炎免疫激活期外周自然杀伤细胞活性降低。
PLoS One. 2014 Feb 10;9(2):e86927. doi: 10.1371/journal.pone.0086927. eCollection 2014.
4
Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.在无症状、E抗原阴性的持续性乙型肝炎病毒感染患者中,产生干扰素-γ或白细胞介素-10的循环CD56dim自然杀伤细胞和CD56+T细胞会扩增。
J Viral Hepat. 2015 Mar;22(3):335-45. doi: 10.1111/jvh.12299. Epub 2014 Sep 3.
5
Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.未治疗的慢性乙型肝炎患者固有和适应性免疫反应细胞因子谱与临床病毒学特征的关系。
BMC Infect Dis. 2020 Jul 14;20(1):509. doi: 10.1186/s12879-020-05233-x.
6
Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.自然杀伤细胞特征与慢性乙型肝炎病毒(HBV)感染患者在聚乙二醇干扰素α-2a 和阿德福韦酯联合治疗后的 HBV 表面抗原清除相关。
J Infect Dis. 2015 Oct 1;212(7):1042-51. doi: 10.1093/infdis/jiv180. Epub 2015 Mar 19.
7
Recovery of circulating CD56 NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg.核苷(酸)类似物治疗后慢性乙型肝炎低 HBsAg 患者循环 CD56 NK 细胞的恢复和 Th17/Treg 的平衡。
Int Immunopharmacol. 2018 Sep;62:59-66. doi: 10.1016/j.intimp.2018.06.043. Epub 2018 Jul 5.
8
Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.活化的自然杀伤细胞会加速慢性乙型肝炎病毒感染患者的肝损伤。
Clin Exp Immunol. 2015 Jun;180(3):499-508. doi: 10.1111/cei.12597. Epub 2015 Apr 12.
9
NK cell phenotypic and functional shifts coincide with specific clinical phases in the natural history of chronic HBV infection.自然杀伤(NK)细胞的表型和功能变化与慢性乙型肝炎病毒(HBV)感染自然史中的特定临床阶段相符。
Antiviral Res. 2017 Apr;140:18-24. doi: 10.1016/j.antiviral.2017.01.007. Epub 2017 Jan 14.
10
TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.HBV 特异性 CD4 T 细胞的 TNF-α/IFN-γ 谱与慢性 HBV 感染中的肝损伤和病毒清除相关。
J Hepatol. 2020 Jan;72(1):45-56. doi: 10.1016/j.jhep.2019.08.024. Epub 2019 Sep 6.

引用本文的文献

1
Anti-HBV treatment partially restores the dysfunction of innate immune cells and unconventional T cells during chronic HBV infection.抗乙肝病毒治疗可部分恢复慢性乙肝病毒感染过程中固有免疫细胞和非常规T细胞的功能障碍。
Front Immunol. 2025 Jul 4;16:1611976. doi: 10.3389/fimmu.2025.1611976. eCollection 2025.
2
Chronic active and chronic inactive hepatitis B virus infection: Comparative study of genetic polymorphism and blood profile measures.慢性活动性和慢性非活动性乙型肝炎病毒感染:基因多态性与血液指标测量的比较研究
PLoS One. 2025 Apr 29;20(4):e0322268. doi: 10.1371/journal.pone.0322268. eCollection 2025.
3
Prevalence and Risk Factors of Type 2 Diabetes Mellitus Among Hepatitis B Virus Patients: A Large Retrospective Cohort Study.

本文引用的文献

1
Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir.在慢性丙型肝炎患者接受索非布韦联合 ledipasvir 治疗后,自然杀伤细胞的恢复主要发生在治疗后时期。
World J Gastroenterol. 2018 Oct 28;24(40):4554-4564. doi: 10.3748/wjg.v24.i40.4554.
2
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.慢性乙型肝炎的预防、诊断和治疗最新进展:美国肝病研究学会2018年乙型肝炎指南
Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800.
3
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
乙肝病毒感染者中2型糖尿病的患病率及危险因素:一项大型回顾性队列研究
Int J Med Sci. 2025 Jan 13;22(3):716-722. doi: 10.7150/ijms.104839. eCollection 2025.
4
Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu-like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll-like receptor 7 agonist ruzotolimod.采用探索性药代动力学和药效学分析预测 Toll 样受体 7 激动剂 ruzotolimod 治疗慢性乙型肝炎健康志愿者和患者出现流感样症状的概率。
Clin Transl Sci. 2024 Aug;17(8):e13896. doi: 10.1111/cts.13896.
5
Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients.血清细胞因子变化谱与 PEG-IFN-α 联合 NA 治疗抑制的慢性乙型肝炎患者 HBsAg 丢失相关。
Front Immunol. 2023 Jan 23;14:1121778. doi: 10.3389/fimmu.2023.1121778. eCollection 2023.
6
Hepatitis B Therapeutic Vaccine: A Patent Review.乙肝治疗性疫苗:专利综述
Pharmaceuticals (Basel). 2022 Dec 12;15(12):1542. doi: 10.3390/ph15121542.
7
The Characteristics of Natural Killer Cells and T Cells Vary With the Natural History of Chronic Hepatitis B in Children.自然杀伤细胞和T细胞的特征随儿童慢性乙型肝炎的自然病程而变化。
Front Pediatr. 2021 Nov 25;9:736023. doi: 10.3389/fped.2021.736023. eCollection 2021.
8
Significantly Decreased Islet Cell Function is Closely Associated with Hyperglycemia in Chronic Hepatitis B Patients.慢性乙型肝炎患者胰岛细胞功能显著降低与高血糖密切相关。
Int J Endocrinol. 2021 Aug 24;2021:1264707. doi: 10.1155/2021/1264707. eCollection 2021.
9
Viral hepatitis update: Progress and perspectives.病毒性肝炎最新进展:成就与展望。
World J Gastroenterol. 2021 Jul 14;27(26):4018-4044. doi: 10.3748/wjg.v27.i26.4018.
10
Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability.乙型肝炎感染过程中的分子机制和病毒变异性的影响。
Viruses. 2021 Jun 18;13(6):1167. doi: 10.3390/v13061167.
EASL 2017 临床实践指南:乙型肝炎病毒感染管理。
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
4
Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.NKp46和NKG2A在乙型肝炎病毒感染中的频率及作用
PLoS One. 2017 Mar 22;12(3):e0174103. doi: 10.1371/journal.pone.0174103. eCollection 2017.
5
Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.自然杀伤细胞有助于乙型肝炎 e 抗原阴性慢性乙型肝炎病毒感染进展过程中的肝损伤,并有助于病毒持续存在。
Clin Microbiol Infect. 2016 Aug;22(8):733.e9-733.e19. doi: 10.1016/j.cmi.2016.05.009. Epub 2016 May 18.
6
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.慢性乙型肝炎中乙型肝炎病毒特异性及全身性T细胞功能障碍
Gastroenterology. 2016 Mar;150(3):684-695.e5. doi: 10.1053/j.gastro.2015.11.050. Epub 2015 Dec 10.
7
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.《亚太地区乙型肝炎管理临床实践指南:2015年更新版》
Hepatol Int. 2016 Jan;10(1):1-98. doi: 10.1007/s12072-015-9675-4. Epub 2015 Nov 13.
8
Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.T 细胞产生的干扰素-γ 和肿瘤坏死因子-α 可减少 HBV 持续存在形式 cccDNA,而不引起细胞溶解。
Gastroenterology. 2016 Jan;150(1):194-205. doi: 10.1053/j.gastro.2015.09.026. Epub 2015 Sep 28.
9
Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells.通过系统生物学重新评估乙型肝炎病毒临床阶段,发现先天免疫反应和 B 细胞的作用未被充分认识。
Hepatology. 2015 Jul;62(1):87-100. doi: 10.1002/hep.27805. Epub 2015 Apr 27.
10
Natural history of chronic hepatitis B: phases in a complex relationship.慢性乙型肝炎的自然史:复杂关系中的各个阶段。
World J Gastroenterol. 2014 Aug 14;20(30):10395-404. doi: 10.3748/wjg.v20.i30.10395.